EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 111 filers reported holding EPIZYME INC in Q2 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $16,155 | -90.4% | 6,462 | -80.3% | 0.00% | -100.0% |
| Q3 2021 | $168,079 | -13.9% | 32,828 | +39.7% | 0.00% | 0.0% |
| Q2 2021 | $195,293 | -37.5% | 23,501 | -34.4% | 0.00% | -33.3% |
| Q1 2021 | $312,236 | -8.7% | 35,848 | +13.8% | 0.00% | 0.0% |
| Q4 2020 | $342,068 | -28.3% | 31,498 | -21.2% | 0.00% | -40.0% |
| Q3 2020 | $476,842 | -39.7% | 39,970 | -18.8% | 0.01% | -44.4% |
| Q2 2020 | $790,602 | +57.4% | 49,228 | +52.0% | 0.01% | +28.6% |
| Q1 2020 | $502,291 | -43.6% | 32,385 | -10.6% | 0.01% | -22.2% |
| Q4 2019 | $891,061 | +138.5% | 36,222 | 0.0% | 0.01% | +125.0% |
| Q3 2019 | $373,630 | -36.4% | 36,222 | -22.6% | 0.00% | -42.9% |
| Q2 2019 | $587,288 | +89.0% | 46,796 | +86.6% | 0.01% | +75.0% |
| Q1 2019 | $310,679 | +101.1% | 25,075 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $154,462 | -41.9% | 25,075 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $265,795 | -21.8% | 25,075 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $340,000 | -8.4% | 25,075 | +19.9% | 0.00% | 0.0% |
| Q1 2018 | $371,000 | +41.1% | 20,920 | 0.0% | 0.00% | +33.3% |
| Q4 2017 | $263,000 | – | 20,920 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |